Results     01-Jun-20
Analysis
Advanced Enzyme Technologies
Impact of pandemic may not be significant
Related Tables
 Advanced Enzymes Technologies: Results
Advanced Enzyme Technologies net sales remained flat at Rs 110.26 crore for quarter ended Mar20. The company operating margins decreased 80 bps to 44.2% leading 2% decrease in operating profits to Rs 48.7 crore.

Other income stood at Rs 1.84 crore compared to Rs 2.64 crore. Interest cost was Rs 69 lakh compared to Rs 58 lakh. Depreciation rose 26% to Rs 6.65 crore. PBT was down 7% to Rs 43.2 crore.

Tax expenses were down 19% to Rs 10.52 crore owing to which the company's net profit reported was down 2% to Rs 32.68 crore. Further considering minority interest, Bottomline of the company was down 3% to Rs 31.33 crore.

In March 2020, the World Health Organisation declared COVID-19 to be a pandemic and several restrictions have been imposed by the Governments across the globe on the travel, goods movement and transportation considering public health and safety measures. Considering the Company's/ Group's products are classified as an ‘essential commodity', management believes that the impact of the pandemic may not be significant. As of today, production facilities remain operational, following enhanced internal safety guidelines. Management has also considered the impact of COVID-19 on the business for the foreseeable future and have concluded that the company has sufficient resources to continue as a going concern.

Consolidated performance for the year ended Mar20

For year ended Mar20, net sales rose 6% to Rs 443.99 crore. The company operating margins increased 240 bps to 45.6%. As a result operating profits rose 11% to Rs 202.33 crore.

Other income rose 12% to Rs 5.64 crore. Interest cost was down 22% to Rs 3.04 crore. Depreciation rose 22% to Rs 25.78 crore. PBT was up 11% to Rs 179.16 crore.

The effective tax rate decreased to 25.7% from 28.4% owing to which the company's net profit rose 15% at Rs 133.05 crore. Further considering minority interest, Bottomline of the company fell 16% to Rs 129.29 crore.

The scrip is currently trading at Rs 151

Previous News
  Advanced Enzyme Technologies consolidated net profit declines 11.86% in the March 2024 quarter
 ( Results - Announcements 11-May-24   14:00 )
  Board of Advanced Enzyme Techs. recommends Interim Dividend
 ( Corporate News - 11-May-24   13:51 )
  Advanced Enzyme Technologies consolidated net profit declines 52.94% in the June 2022 quarter
 ( Results - Announcements 06-Aug-22   12:28 )
  Advanced Enzyme spurts after Nalanda India Equity Fund hikes stake
 ( Hot Pursuit - 20-Sep-22   09:58 )
  Advanced Enzyme Technologies consolidated net profit rises 12.57% in the June 2019 quarter
 ( Results - Announcements 09-Aug-19   14:36 )
  Advanced Enzyme Technologies Ltd leads gainers in 'A' group
 ( Hot Pursuit - 20-Sep-22   12:00 )
  Advanced Enzyme Technologies standalone net profit rises 15.45% in the June 2020 quarter
 ( Results - Announcements 12-Aug-20   12:46 )
  Advanced Enzyme raises Rs 122.84 crore from anchor investors
 ( IPO Centre - IPO News 20-Jul-16   12:55 )
  Advanced Enzyme Tech gains after Q3 PAT rises 52% YoY
 ( Hot Pursuit - 12-Feb-24   10:39 )
  Advanced Enzyme Technologies Chief Business Officer resigns
 ( Corporate News - 08-Jan-19   15:42 )
  Board of Advanced Enzyme Techs. recommends Final Dividend
 ( Corporate News - 11-May-24   13:43 )
Other Stories
  Apollo Hospitals Enterprise
  04-Jun-24   10:04
  ITL Industries
  01-Jun-24   02:14
  International Combustion (India)
  31-May-24   11:32
  Fluidomat
  31-May-24   11:28
  ISGEC Heavy Engineering
  31-May-24   11:24
  Sreeleathers
  31-May-24   11:20
  Cummins India
  31-May-24   11:18
  Bata India
  31-May-24   09:55
  Tata Steel
  31-May-24   08:36
  India Nippon Electricals
  31-May-24   07:03
Back Top